Preclinical Cancer Chemoprevention Studies Using Animal Model of Inflammation-Associated Colorectal Carcinogenesis
Author:
Open Access
Abstract
Inflammation is involved in all stages of carcinogenesis. Inflammatory bowel disease, such as ulcerative colitis and Crohn’s disease is a longstanding inflammatory disease of intestine with increased risk for colorectal cancer (CRC). Several molecular events involved in chronic inflammatory process are reported to contribute to multi-step carcinogenesis of CRC in the inflamed colon. They include over-production of free radicals, reactive oxygen and nitrogen species, up-regulation of inflammatory enzymes in arachidonic acid biosynthesis pathway, up-regulation of certain cytokines, and intestinal immune system dysfunction. In this article, firstly I briefly introduce our experimental animal models where colorectal neoplasms rapidly develop in the inflamed colorectum. Secondary, data on preclinical cancer chemoprevention studies of inflammation-associated colon carcinogenesis by morin, bezafibrate, and valproic acid, using this novel inflammation-related colorectal carcinogenesis model is described.Keywords
This publication has 117 references indexed in Scilit:
- Development of an Inflammation-Associated Colorectal Cancer Model and Its Application for Research on Carcinogenesis and ChemopreventionInternational Journal of Inflammation, 2012
- Inflammation in the Intestinal Tract: Pathogenesis and TreatmentDigestive Diseases, 2009
- New clinical developments in histone deacetylase inhibitors for epigenetic therapy of cancerJournal of Hematology & Oncology, 2009
- Mouse models for the study of colon carcinogenesisCarcinogenesis, 2008
- Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?Cardiovascular Diabetology, 2008
- PPARα agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibitionProceedings of the National Academy of Sciences, 2008
- PPAR Ligands for Cancer ChemopreventionPPAR Research, 2008
- Global gene expression analysis of the mouse colonic mucosa treated with azoxymethane and dextran sodium sulfateBMC Cancer, 2007
- Morin (3,5,7,2′,4′-Pentahydroxyflavone) Abolishes Nuclear Factor-κB Activation Induced by Various Carcinogens and Inflammatory Stimuli, Leading to Suppression of Nuclear Factor-κB–Regulated Gene Expression and Up-regulation of ApoptosisClinical Cancer Research, 2007
- Anti‐tumor mechanisms of valproate: A novel role for an old drugMedicinal Research Reviews, 2002